<- Go Home
Embecta Corp.
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Market Cap
$198.7M
Volume
650.4K
Cash and Equivalents
$184.9M
EBITDA
$332.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$645.5M
Profit Margin
61.92%
52 Week High
$15.55
52 Week Low
$2.77
Dividend
1.19%
Price / Book Value
-0.32
Price / Earnings
1.78
Price / Tangible Book Value
-0.31
Enterprise Value
$1.4B
Enterprise Value / EBITDA
4.09
Operating Income
$289.5M
Return on Equity
16.43%
Return on Assets
16.84
Cash and Short Term Investments
$184.9M
Debt
$1.4B
Equity
-$626.1M
Revenue
$1.0B
Unlevered FCF
$251.9M
Sector
Health Care Equipment and Supplies
Category
N/A